Results 171 to 180 of about 13,819 (183)

Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Pharmacotherapy, 2008
Oliver A Cornely
exaly  

Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections

Mycoses, 2015
Chiara Cattaneo, Alessandro Re, Giuseppe Rossi   +2 more
exaly  

Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed‐release tablet and intravenous posaconazole

Pediatric Transplantation, 2020
Valeria Bernardo, Inci Yildirim
exaly  

Posaconazole oral dose and plasma levels in pediatric hematology‐oncology patients

European Journal of Haematology, 2018
Massimo Berger, Mariadelfina Molinaro, Simone Cesaro   +2 more
exaly  

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations

Mycoses, 2019
Jan-willem Alffenaar, Anne-grete Märtson, Edwin R Van Den Heuvel   +2 more
exaly  

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology–oncology patients: a retrospective cohort study

Cancer Medicine, 2014
Melissa D Johnson, Qufu Wei
exaly  

Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single‐centre retrospective study in Korea and clinical considerations

Mycoses, 2015
Sung-yeon Cho, Dong-gun Lee, Su Mi Choi
exaly  

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison

Mycoses, 2018
Mar Tormo, Marisa Calabuig, Paula Amat
exaly  

Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes

European Journal of Haematology, 2016
Torsten Dahlén, Per Ljungman, Ola Blennow   +2 more
exaly  

A new, broad-spectrum azole antifungal: posaconazole ? mechanisms of action and resistance, spectrum of activity

Mycoses, 2006
exaly